Mes choix et mouvements sont basés sur l'analyse technique des graphiques,merci pour votre attention et fidélité,le succès de chaque individu dépend de son fond, le dévouement,le désir et la motivation. Soutenir trades actions biotechs en faisant un Don via le bouton Paypal(totalement sécurisé) merci pour vôtre contribution.
Articles les plus consultés
-
francis 13 Version sans publicité Marchés Actualités Analyses Crypto Fonds Graphiques Technique Brokers Outils Portefe...
-
6% Hydroxyethyl Starch 130 / 0.4 in 0.9% Injection de chlorure de sodium (Voluven 500 mL freeflex flexible en plastique intraveineuse solut...
-
Top Gaining Stocks % Chg Dernier Symb Compagnie Le volume 16,22% 2.15 SRNE Sorrento Therapeut 7030 10,92% 2,64 CIE Cobalt Inte...
-
Pre Market Top Gainers prénom Dernier Chg. % Vol. Iridium 14.95 + 39.07% 0,60K Mondialisation de l'Inde. 0,4800 + 18,52% 1,80K...
-
Pre Market Top Gainers prénom Dernier Chg. % Vol. Oracle Corporation 51.30 + 10,73% 58.90K Staples Inc 9.25 + 6,81% 12,31K Delcat...
-
Pre Market Top Gainers prénom Dernier Chg. % Vol. Delcath 0.1230 + 24,24% 196,67K Neos Therapeutics I. 10.50 +16.67% 34.36K Enpha...
-
Citoyens_Français @citoyenneFrance 8 juin Plus Attali : « Les élus n’ont plus de pouvoir et voici votre avenir » - Effr......
-
Pre Market Top Gainers prénom Dernier Chg. % Vol. Lipocine In 5.32 + 32,34% 38.64K Enphase Energy Inc 0,938 + 17,57% 10,37K Delca...
-
28 juin 2017 Nom du médicament et numéro de demande Ingrédient actif Formulaire de posologie / itinéraire Soumission Compagnie ...
-
Plus fortes hausses en préouverture Nom Dernier Var.% Vol. DragonWave Inc 1,3900 +25,23% 3,55K Alibaba 139,95 +11,35% 1,40M MoSys...
vendredi 18 mai 2018
Cathryn Tames Receives the Rite Aid Foundation’s KIDCHAMPSM Award | Business Wire
Cathryn Tames Receives the Rite Aid Foundation’s KIDCHAMPSM Award | Business Wire: The Rite Aid Foundation announced today that Cathryn Tames, Executive Director of the Children’s Developmental Center in Richland, Washington, has bee
Resumen: BioClin Therapeutics, Inc. anuncia la presentación del póster de B-701 en la edición 2018 de la reunión anual de la Sociedad Estadounidense de Oncología Clínica (ASCO) | Business Wire
Resumen: BioClin Therapeutics, Inc. anuncia la presentación del póster de B-701 en la edición 2018 de la reunión anual de la Sociedad Estadounidense de Oncología Clínica (ASCO) | Business Wire: BioClin Therapeutics, Inc., una compañía dedicada al desarrollo de fármacos clínicos, ha anunciado hoy que los datos derivados de su estudio en curso
Samenvatting: Takeda belicht breed Oncologie-Portfolio en Pipeline Data tijdens de jaarlijkse bijeenkomsten van de American Society of Clinical Oncology (ASCO) en het congres van de European Hematology Association (EHA) | Business Wire
Samenvatting: Takeda belicht breed Oncologie-Portfolio en Pipeline Data tijdens de jaarlijkse bijeenkomsten van de American Society of Clinical Oncology (ASCO) en het congres van de European Hematology Association (EHA) | Business Wire: Takeda Pharmaceutical Company Limited (TSE: 4502) kondigde vandaag aan dat het bedrijf in totaal 14 door Takeda Oncology-gesponsorde presentaties zal
NeoTract Announces American Urological Association (AUA) Recommendation of UroLift® System as a Standard of Care Option for the Treatment of Enlarged Prostate | Business Wire
NeoTract Announces American Urological Association (AUA) Recommendation of UroLift® System as a Standard of Care Option for the Treatment of Enlarged Prostate | Business Wire: NeoTract Announces American Urological Association Recommendation of UroLift® System as a Standard of Care Option for Enlarged Prostate Treatment
jeudi 17 mai 2018
EURONEXT 457SX
|
|
Protalex Announces Presentation Highlighting PRTX-100 Phase 1b Clinical Data in Patients with Immune Thrombocytopenia at the European Hematology Association 23rd Annual Meeting | Business Wire
Protalex Announces Presentation Highlighting PRTX-100 Phase 1b Clinical Data in Patients with Immune Thrombocytopenia at the European Hematology Association 23rd Annual Meeting | Business Wire: Protalex, Inc. (OTCQB: PRTX), a clinical-stage biopharmaceutical company, today announced that preliminary results from its European Phase 1b open-lab
Flatiron Health Announces Research to Be Presented at American Society of Clinical Oncology 2018 Annual Meeting | Business Wire
Flatiron Health Announces Research to Be Presented at American Society of Clinical Oncology 2018 Annual Meeting | Business Wire: Flatiron Health today announced 11 abstracts accepted for presentation at the 2018 American Society for Clinical Oncology (ASCO) Annual Meeting, which
Inscription à :
Articles (Atom)